Back to Search Start Over

LBA1IMpower133: Primary efficacy and safety + CNS-related adverse events in a phase I/III study of first-line (1L) atezolizumab + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC).

Authors :
Mok, T S K
Reck, M
Horn, L
Lam, S
Shames, D S
Liu, J
Kabbinavar, F
Lin, W
Sandler, A
Liu, S V
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart.
Publication Year :
2018

Subjects

Subjects :
*HEMATOMA

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133479282
Full Text :
https://doi.org/10.1093/annonc/mdy483
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details